Translational Pulmonary and Immunology Research Center

Analysis

Translational Pulmonary and Immunology Research Center is a registered charity in United States, based in Long Beach, CA. It received its IRS tax-exemption ruling in July 2015, 11 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a hospital or medical research organisation under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Translational Pulmonary and Immunology Research Center reported income of $10.6m and spending of $9.6m, spending 91% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $8.6m to $10.6m (+22%), an average of +5.2% a year. The sharpest change came in the year to December 2020, when income rose by 76%. Over the whole period it spent 97% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Translational Pulmonary and Immunology Research Center sits at the 84th percentile: it is larger than about 84% of them. Against every charity in United States with reported income it ranks in the 95th percentile, and in the 96th percentile within CA. Charities of a similar size with the same main cause include Chosen Valley Care Center Inc ($10.6m), Council on Chemical Abuse Inc ($10.6m) and North Broward Hospital District Charitable Foundation Inc ($10.6m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 6.9% and program service revenue 84% of the total. Compensation of current officers, directors and key employees was $1.3m (14% of expenses). Other salaries and wages came to $676k. At year end it held assets of $6.2m against liabilities of $2.8m, net assets of $3.3m. It reported 59 employees.